The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

Dividend-paying stocks are a traditional defensive play, while healthcare faces fewer trade and economic headwinds than most ...

OUSA is an ETF that provides exposure to high-quality U.S. companies that pay regular dividends. The fund tracks the O’Shares ...

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

Dean Li, president of Merck Research Laboratories, told the meeting that cardiovascular disease is a big opportunity as it remains an epidemic, killing 35 million people during the pandemic while ...

New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...

Lead study author Douglas Johns of Merck Research Labs acknowledged at that AHA while the initial results are encouraging, "more clinical studies are needed to confirm these findings, given ...

Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.

Wilmington, Delaware, Transparency Market Research Inc. –, March 07, 2025 (GLOBE NEWSWIRE) -- Rising awareness about women’s ...

On March 11 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially ...